drugset / Trial / NCT03697889

A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult Volunteers

NCT03697889

Phase 1 Completed 28 enrolled McNeil AB
RandomizedCrossoverOpen-labelTreatment

Summary

This is a research study designed to evaluate the rate and extent of absorption of Naproxen from a novel Naproxen sodium tablet and Nalgesin naproxen sodium 275 mg.

Timeline

Start
2018-12-03
Primary completion
2018-12-17
Completion
2019-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule 275 mg Oral

Indications

No indication recorded.